LEGN
Legend Biotech Corp
19.10$
+2.1%
vs. previous close
Closing price · As of: Oct 7, 2026
Statements
Cash Flow
Legend Biotech Corp (LEGN) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Operating Cash Flow" came in at -21 million USD. Tick rows to compare them in a chart.
All figures in millions of USD.
Tick rows to compare them in a chart (up to 4)
| Line item | Q1 19 | Q2 19 | Q3 19 | Q4 19 | Q1 20 | Q2 20 | Q3 20 | Q4 20 | Q1 21 | Q2 21 | Q3 21 | Q4 21 | Q1 22 | Q2 22 | Q3 22 | Q4 22 | Q1 23 | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -4.3 | -39 | 20 | -60 | -46 | -57 | -64 | -56 | -27 | -58 | -45 | -70 | -79 | -0.7 | -72 | -50 | -139 | -98 | -61 | -96 | 16 | -1.7 | -76 | -82 | -104 | -13 | 29 | -106 | -85 | -21 | -183 | |
| 0.6 | – | – | 5.3 | 2.0 | 3.1 | 3.0 | 1.8 | 3.7 | 6.7 | 3.5 | 3.7 | 3.9 | 4.1 | 5.1 | 5.2 | 5.2 | 4.7 | 5.2 | 5.4 | 5.7 | 5.4 | 3.9 | 6.8 | 5.2 | 5.9 | 5.9 | 12 | 16 | 12 | 45 | |
| 0.4 | – | – | 1.3 | 0.3 | 0.4 | 1.0 | 3.1 | 2.3 | 8.0 | 6.9 | 5.2 | 5.7 | 9.5 | 10 | 9.0 | 7.1 | 16 | 12 | 13 | 19 | 22 | 15 | 13 | 16 | 19 | 15 | 15 | 19 | 17 | 67 | |
| -0.6 | -10.0 | 48 | – | -0.7 | 78 | 2.2 | 13 | 54 | -43 | 80 | 19 | -27 | – | 151 | 151 | 151 | 151 | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| 8.2 | – | – | 24 | 9.5 | 7.8 | 6.2 | -49 | 59 | 86 | 33 | 38 | -27 | 87 | 55 | 59 | -32 | -18 | -1.8 | -12 | 94 | 3.0 | 2.0 | -80 | -74 | -37 | 77 | -31 | -76 | -101 | -130 | |
| 19 | 0.0 | 0.0 | 39 | 15 | 11 | 7.1 | 12 | 15 | 29 | 13 | 3.2 | 12 | 0.6 | 1.7 | 7.5 | 4.3 | 6.1 | 5.5 | 6.8 | 6.2 | 3.4 | 2.1 | 2.4 | 2.0 | 9.2 | 5.0 | 21 | 26 | 21 | 73 | |
| -115 | -36 | -21 | 113 | -17 | -9.2 | -59 | 61 | -17 | -169 | -106 | 97 | -233 | 2.6 | 128 | 25 | 16 | -122 | -209 | 408 | -396 | -696 | 329 | -88 | 257 | -166 | -20 | 640 | -169 | -120 | 332 | |
| 0.0 | – | – | – | -0.1 | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| 29 | -1.6 | -1.6 | – | -1.6 | -2.6 | -2.6 | -2.6 | -0.6 | -0.6 | -0.4 | -0.4 | -0.4 | – | -2.3 | -2.3 | -2.3 | -2.3 | – | – | – | – | -1.2 | -0.9 | -0.8 | -1.3 | -0.6 | -1.0 | -1.3 | -45 | -48 | |
| 29 | -7.2 | -0.2 | -6.7 | 149 | 460 | 9.7 | 0.7 | 0.2 | 302 | 1.1 | 324 | 0.0 | 1.0 | 378 | -0.8 | -0.4 | 790 | 1.0 | 0.9 | 0.8 | 1.0 | 4.2 | -0.3 | 0.7 | -1.0 | 0.7 | -0.6 | -1.2 | 168 | 167 | |
| -90 | -82 | -1.4 | 47 | 85 | 394 | -113 | 6.3 | -43 | 76 | -150 | 351 | -311 | 2.0 | 433 | -27 | -126 | 573 | -270 | 314 | -380 | -696 | 258 | -173 | 155 | -175 | 12 | 623 | -255 | 27 | 406 | |
| -24 | -39 | 20 | -99 | -61 | -68 | -71 | -68 | -42 | -86 | -57 | -73 | -91 | -1.3 | -74 | -57 | -143 | -104 | -66 | -102 | 9.3 | -5.1 | -78 | -84 | -106 | -22 | 24 | -127 | -111 | -41 | -256 |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 7, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.